Cargando…

The Rodent Models of Dyskinesia and Their Behavioral Assessment

Dyskinesia, a major motor complication resulting from dopamine replacement treatment, manifests as involuntary hyperkinetic or dystonic movements. This condition poses a challenge to the treatment of Parkinson's disease. So far, several behavioral models based on rodent with dyskinesia have bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Qiwei, Zhong, Shaoping, Tan, Yang, Zeng, WeiQi, Wang, Ji, Cheng, Chi, Yang, Xiaoman, Wu, Yi, Cao, Xuebing, Xu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6798181/ https://www.ncbi.nlm.nih.gov/pubmed/31681132 http://dx.doi.org/10.3389/fneur.2019.01016

Ejemplares similares

TRH Analog, Taltirelin Improves Motor Function of Hemi-PD Rats Without Inducing Dyskinesia via Sustained Dopamine Stimulating Effect
por: Zheng, Cong, et al.
Publicado: (2018)

Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry
por: Zhang, Xiaoqian, et al.
Publicado: (2021)

Transcranial Magnetic Stimulation Alleviates Levodopa-Induced Dyskinesia in Parkinson's Disease and the Related Mechanisms: A Mini-Review
por: Wu, Yi, et al.
Publicado: (2021)

Concussion-Induced Oromandibular Dyskinesia
por: Zhang, Brenda, et al.
Publicado: (2023)

TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone
por: Zheng, Cong, et al.
Publicado: (2018)

Factors Associated With Dyskinesia in Parkinson's Disease in Mainland China
por: Zhou, Xun, et al.
Publicado: (2019)

Behavioral Assessment of Sensory, Motor, Emotion, and Cognition in Rodent Models of Intracerebral Hemorrhage
por: Shi, Xiaoyu, et al.
Publicado: (2021)

Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia
por: Pahwa, Rajesh, et al.
Publicado: (2022)

Tardive Dyskinesia Following Low-Dose Risperidone
por: Rokon, Ahmad E, et al.
Publicado: (2022)

Improvement of Deep Brain Stimulation in Dyskinesia in Parkinson's Disease: A Meta-Analysis
por: Liu, Yun, et al.
Publicado: (2019)

Belly Dancer's Dyskinesia: A Glimpse of a Rare Phenomenon
por: GUPTA, ASHUTOSH, et al.
Publicado: (2017)

Intestinal Decontamination Therapy for Dyskinesia and Motor Fluctuations in Parkinson's Disease
por: Baizabal-Carvallo, José Fidel, et al.
Publicado: (2021)

Case report: Reversible encephalopathy caused by dyskinesia-hyperpyrexia syndrome
por: Luo, Bohan, et al.
Publicado: (2023)

Aberrant Sensory Gating of the Primary Somatosensory Cortex Contributes to the Motor Circuit Dysfunction in Paroxysmal Kinesigenic Dyskinesia
por: Liu, Yo-Tsen, et al.
Publicado: (2018)

LY354740 Reduces Extracellular Glutamate Concentration, Inhibits Phosphorylation of Fyn/NMDARs, and Expression of PLK2/pS129 α-Synuclein in Mice Treated With Acute or Sub-Acute MPTP
por: Tan, Yang, et al.
Publicado: (2020)

Neurochemical and Behavioral Consequences of Ethanol and/or Caffeine Exposure: Effects in Zebrafish and Rodents
por: Clayman, Carly L., et al.
Publicado: (2022)

Delayed Presentation of Antipsychotic Withdrawal Tardive Dyskinesia: A Case Report
por: Solanki, Siddhant, et al.
Publicado: (2023)

Genetics of Paroxysmal Dyskinesia: Novel Variants Corroborate the Role of KCNA1 in Paroxysmal Dyskinesia and Highlight the Diverse Phenotypic Spectrum of KCNA1- and SLC2A1-Related Disorders
por: Kegele, Josua, et al.
Publicado: (2021)

Effects and molecular mechanism of chitosan-coated levodopa nanoliposomes on behavior of dyskinesia rats
por: Cao, Xuebing, et al.
Publicado: (2016)

Blood Flow and Glucose Metabolism Dissociation in the Putamen Is Predictive of Levodopa Induced Dyskinesia in Parkinson's Disease Patients
por: Aljuaid, Maram, et al.
Publicado: (2019)

Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan
por: Zhai, Heng, et al.
Publicado: (2021)

Opioidergic Modulation of Striatal Circuits, Implications in Parkinson's Disease and Levodopa Induced Dyskinesia
por: Sgroi, Stefania, et al.
Publicado: (2018)

Case Report: Long-Term Suppression of Paroxysmal Kinesigenic Dyskinesia After Bilateral Thalamotomy
por: Murakami, Masato, et al.
Publicado: (2021)

Case Report: A Case of Concomitant Paroxysmal Kinesigenic Dyskinesia and Epilepsy: Can We Treat Two Birds With One Stone?
por: Geng, Jun-Hong, et al.
Publicado: (2022)

Rodent behavior following a dural inflammation model with anti-CGRP migraine medication treatment
por: Reducha, Philip V., et al.
Publicado: (2023)

Screening of the TMEM151A Gene in Patients With Paroxysmal Kinesigenic Dyskinesia and Other Movement Disorders
por: Ma, Ling-Yan, et al.
Publicado: (2022)

Case report: Blepharospasm in peak-dose dyskinesia may benefit from amantadine in Parkinson's disease
por: Fan, Qian-Ya, et al.
Publicado: (2022)

Rodent Models of Optic Neuritis
por: Redler, Yael, et al.
Publicado: (2020)

Incidence of tardive dyskinesia: a comparison of long-acting injectable and oral paliperidone clinical trial databases
por: Gopal, S, et al.
Publicado: (2014)

Remnants of Cardinal Symptoms of Parkinson's Disease, Not Dyskinesia, Are Problematic for Dyskinetic Patients Performing Activities of Daily Living
por: Goubault, Etienne, et al.
Publicado: (2019)

Intrastriatal Memantine Infusion Dampens Levodopa-Induced Dyskinesia and Motor Deficits in a Mouse Model of Hemiparkinsonism
por: Ogawa, Masatoshi, et al.
Publicado: (2019)

Time-dependent alterations in the rat nigrostriatal system after intrastriatal injection of fibrils formed by α–Syn and tau fragments
por: Yang, Xiaoman, et al.
Publicado: (2022)

Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia
por: Jeong, Eun Hye, et al.
Publicado: (2018)

Evaluation of the Direct Effect of Bilateral Deep Brain Stimulation of the Subthalamic Nucleus on Levodopa-Induced On-Dyskinesia in Parkinson's Disease
por: Li, Jiping, et al.
Publicado: (2021)

Case report: Pallidal deep brain stimulation for treatment of tardive dystonia/dyskinesia secondary to chronic metoclopramide medication
por: Nagel, Johanna M., et al.
Publicado: (2023)

Magnetic Resonance Elastography of Rodent Brain
por: Bigot, Mathilde, et al.
Publicado: (2018)

Clinical characteristics and reaction to dopaminergic treatment of drug-naïve patients with Parkinson's disease in central China: A cross sectional study
por: Zeng, Weiqi, et al.
Publicado: (2023)

On the neuronal circuitry mediating l-DOPA-induced dyskinesia
por: Cenci, M. Angela, et al.
Publicado: (2018)

Altered Intra- and Inter-Network Connectivity in Drug-Naïve Patients With Early Parkinson’s Disease
por: Zeng, Weiqi, et al.
Publicado: (2022)

Amantadine ER (Gocovri(®)) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's Disease
por: Hauser, Robert A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a62ok16h35f83u7khvbmdqpfj6